PrP(106-126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH-oxidase independently of PrPc
Prion diseases are characterised by severe neural lesions linked to the presence of an abnormal protease-resistant isoform of cellular prion protein (PrPc). The peptide PrP(106-126) is widely used as a model of neurotoxicity in prion diseases. Here, we examine in detail the intracellular signalling cascades induced by PrP(106-126) in cortical neurons and the participation of PrPc. We show that PrP(106-126) induces the activation of subsets of intracellular kinases (e.g.;ERK1/2), early growth response 1 synthesis and induces caspase-3 activity, all of which are mediated by nicotinamide adenine dinucleotide phosphate hydrogen-oxidase activity and oxidative stress. However, cells lacking PrPc are similarly affected after peptide exposure, and this questions the involvement of PrPc in these effects. © 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Main Authors: | , , , , , , , , , |
---|---|
Format: | journal article biblioteca |
Language: | eng |
Published: |
2005
|
Online Access: | http://hdl.handle.net/20.500.12792/1688 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Published 2005